Authors Laurenzi M
Received 30 July 2011
Accepted for publication 1 August 2011
Published 31 January 2012 Volume 2012:7 Pages 33—34
Senior Medical Director, Internal Medicine Medical Affairs, Forest Research Institute, Jersey City, NJ, USA
The article “Optimizing management of chronic obstructive pulmonary disease in the upcoming decade” by Russell et al1 (January edition of the International Journal of Chronic Obstructive Pulmonary Disease) provides an overview of the pathophysiology of chronic obstructive pulmonary disease (COPD) and discusses emerging treatment options for managing this disease. I wish to draw your attention to the general information and clinical trial data presented on roflumilast. Several inaccuracies have been noticed in this section as well as in Table 2 of the article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]